Routine buyback disclosure — no material new information. The program is proceeding as announced. Monitor for any acceleration or completion of the DKK 15 billion authorization, but this filing alone does not warrant a trading response.
Price Chart
Executive Summary
Novo Nordisk filed a routine 6-K disclosing weekly share repurchase transactions under its existing DKK 15 billion buyback program. Since the program's initiation on 6 May 2026, the company has repurchased 4,000,000 B shares for DKK 1,158,452,492 through 4 June 2026, and a total of 18,759,179 B shares (DKK 4,958,452,482) since 4 February 2026. This is a routine capital allocation update with no material new information.
Key Facts
- Overall share repurchase program of up to DKK 15 billion over 12 months beginning 4 February 2026
- Under the tranche initiated 6 May 2026, up to DKK 11,200,000,010.45 in B shares to be repurchased through 1 February 2027
- Since 4 February 2026, repurchased 18,759,179 B shares at avg price DKK 264.32, total value DKK 4,958,452,482
- Company holds 35,944,480 B shares as treasury shares, representing 0.8% of total share capital of 4,465,000,000 shares
- Weekly update covers transactions from 1-4 June 2026: 870,000 B shares repurchased for DKK 245,181,796
Financial Impact
DKK 4.96 billion deployed in buybacks since February 2026, representing ~33% of the DKK 15 billion program
Risk Factors
- No new risks identified — this is a routine operational update on an existing buyback program
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-003963 |
| Document: 0001171843-26-003963-index-headers.html | 0001171843-26-003963 |
| Document: 0001171843-26-003963-index.html | 0001171843-26-003963 |
| Document: 0001171843-26-003963.txt | 0001171843-26-003963 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 8, 2026 20w ago | 6-K | $41.25 $46.09 | ▲ +11.73% | ▲ +8.42% | $38.98 (−5.50%) |
May 27, 2026 21w ago | 6-K | $44.80 $46.30 | ▲ +3.35% | ▲ +1.47% | $38.98 (−12.99%) |
May 22, 2026 22w ago | 6-K | $43.80 $44.78 | ▲ +2.24% | ▼ −0.95% | $38.98 (−11.00%) |
Apr 13, 2026 28w ago | 6-K | $38.08 $49.85 | ▲ +30.91% | ▲ +21.99% | $38.98 (+2.36%) |
Apr 7, 2026 29w ago | 6-K | $35.92 $50.00 | ▲ +39.20% | ▲ +25.93% | $38.98 (+8.52%) |
Mar 27, 2026 30w ago | 6-K | $35.29 $46.84 | ▲ +32.73% | ▲ +16.66% | $38.98 (+10.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers